Emodin suppresses maintenance of stemness by augmenting proteosomal degradation of epidermal growth factor receptor/epidermal growth factor receptor variant III in glioma stem cells. - Wikidata - wikimedia - TriplyDB

Emodin suppresses maintenance of stemness by augmenting proteosomal degradation of epidermal growth factor receptor/epidermal growth factor receptor variant III in glioma stem cells.

Emodin suppresses maintenance of stemness by augmenting proteosomal degradation of epidermal growth factor receptor/epidermal growth factor receptor variant III in glioma stem cells.

http://www.wikidata.org/entity/Q34999744

about

San-Huang-Xie-Xin-Tang Constituents Exert Drug-Drug Interaction of Mutual Reinforcement at Both Pharmacodynamics and Pharmacokinetic Level: A Review Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics.Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.Effects of combined radiosurgery and temozolomide therapy on epidermal growth factor receptor and variant III in glioblastoma multiforme.

P2860

Q28075782-A70DB1A8-D17C-49BA-9ECC-C5A518D1B204 Q37719988-147C2F68-9D77-4855-9376-EA2870A6896E Q38836434-D444D2D9-EDD3-4201-B17E-855721547007 Q38989377-DA5EC07A-E36E-43C4-95B3-D2C4867EFDFA Q55072630-427453A3-7D20-44B6-BA96-532C4412F9EF

P2860

Emodin suppresses maintenance of stemness by augmenting proteosomal degradation of epidermal growth factor receptor/epidermal growth factor receptor variant III in glioma stem cells.

http://www.wikidata.org/entity/Q34999744

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@ast

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@en

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@nl

type

label

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@ast

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@en

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@nl

prefLabel

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@ast

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@en

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@nl

P1433

Q34999744-780B77C2-FBED-4B99-99E4-17655A8627BB

P1476

Q34999744-5704CD3B-1888-405E-B5F4-870B070CDF46

P2093

Q34999744-33B379DE-0A63-4C1A-93C0-E5C1FD4009C1

Q34999744-53D40E78-6C9C-4409-9B94-1E587992E862

Q34999744-6883580F-50C1-42A5-8A71-B870B78E8523

Q34999744-BE0E7C53-0446-4973-95C8-0D8E9141DB2D

Q34999744-C084AA98-01A3-47F0-BFC8-52AE5A7B0EF7

Q34999744-D6ADF664-864F-42D6-A401-7668F9350AD1

P2860

Q34999744-08A4D93F-6CF1-49BF-9C5A-457BF1D33311

Q34999744-0E32F9BA-A88C-491E-B4E6-1FA3AD272366

Q34999744-1484FF3C-090E-461A-B5F2-60FEA2962559

Q34999744-20F0B5AF-E952-4C31-B5F1-66461BB43353

Q34999744-2DC20E9F-C467-4C0F-B4B1-1BDECAE04A0E

Q34999744-2EF6C43D-5EA6-4958-8D1E-44E6C6A1E2E9

Q34999744-456758F2-7F61-41F2-863B-9F64718E32FA

Q34999744-46B0159B-EA26-428D-9EB8-974F63B79A48

Q34999744-4B51FFF3-8549-4111-BA52-7337D02FCE70

Q34999744-4BEABA80-C9A4-4312-9641-0A413C77FCFD

P304

Q34999744-D60CF37A-D015-4009-9C4E-FC26CC070391

P31

Q34999744-A3D6723D-16E3-421A-8FBF-622EA50F3400

P356

Q34999744-0D9451C5-C338-43BF-83D5-A67DBEEC6AAD

P433

Q34999744-6CA5758B-DBBB-4B8B-8F1E-7E470749492B

P478

Q34999744-5B58D6F3-D1BB-4F61-8A50-6EF5AEFEB16F

P577

Q34999744-E8351637-0980-4237-AC9A-0769CA2063F8

P698

Q34999744-79E71460-B249-4766-B878-93E93ED10094

P932

Q34999744-8D5DD26D-5CBB-4553-9ACB-EF8B5DAD6F23

P356

P1433

Stem Cells and Development

P1476

Emodin suppresses maintenance ...... iant III in glioma stem cells.

@en

P2093

Inhye Lim

http://www.w3.org/2001/XMLSchema#string

Jeongyub Kim

http://www.w3.org/2001/XMLSchema#string

Ji-Yun Lee

http://www.w3.org/2001/XMLSchema#string

Jieun Jung

http://www.w3.org/2001/XMLSchema#string

Jong-Seon Lee

http://www.w3.org/2001/XMLSchema#string

Myung-Jin Park

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective identification of tumorigenic breast cancer cells

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Identification and expansion of human colon-cancer-initiating cells

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Identification of human brain tumour initiating cells

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90

Targeting the dynamic HSP90 complex in cancer

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

P304

284-295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/SCD.2014.0210

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25229646

http://www.w3.org/2001/XMLSchema#string

P932

4303020

http://www.w3.org/2001/XMLSchema#string